IS5220A - Sýkló-oxýgenasa-2 valvíst karprófen til meðhöndlunar á sársauka og bólgu hjá hundum - Google Patents

Sýkló-oxýgenasa-2 valvíst karprófen til meðhöndlunar á sársauka og bólgu hjá hundum

Info

Publication number: IS5220A
Authority: IS; Iceland
Prior art keywords: carprofen; oxygenase; cyclo; dogs; inflammation
Prior art date: 1997-05-05

Application number

IS5220A

Other languages

English (en)

Inventor

Marie Lundy Kristin

Paul Ricketts Anthony

Original Assignee

Pfizer Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-05-05

Filing date

1999-10-19

Publication date

1999-10-19

1999-10-19 Application filed by Pfizer Inc. filed Critical Pfizer Inc.

1999-10-19 Publication of IS5220A publication Critical patent/IS5220A/is

Links

241000282472 Canis lupus familiaris Species 0.000 title 1
102000010907 Cyclooxygenase 2 Human genes 0.000 title 1
108010037462 Cyclooxygenase 2 Proteins 0.000 title 1
206010061218 Inflammation Diseases 0.000 title 1
IVUMCTKHWDRRMH-UHFFFAOYSA-N carprofen Chemical compound C1=CC(Cl)=C[C]2C3=CC=C(C(C(O)=O)C)C=C3N=C21 IVUMCTKHWDRRMH-UHFFFAOYSA-N 0.000 title 1
229960003184 carprofen Drugs 0.000 title 1
230000004054 inflammatory process Effects 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)
Medicinal Preparation (AREA)

IS5220A 1997-05-05 1999-10-19 Sýkló-oxýgenasa-2 valvíst karprófen til meðhöndlunar á sársauka og bólgu hjá hundum IS5220A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US4563597P	1997-05-05	1997-05-05
PCT/IB1998/000662 WO1998050033A1 (en)	1997-05-05	1998-05-01	Cox-2 selective carprofen for treating pain and inflammation in dogs

Publications (1)

Publication Number	Publication Date
IS5220A true IS5220A (is)	1999-10-19

Family

ID=21939053

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS5220A IS5220A (is)	1997-05-05	1999-10-19	Sýkló-oxýgenasa-2 valvíst karprófen til meðhöndlunar á sársauka og bólgu hjá hundum

Country Status (32)

Country	Link
EP (1)	EP0988034A1 (is)
JP (1)	JP2000513020A (is)
KR (2)	KR20040004406A (is)
CN (1)	CN1255059A (is)
AP (1)	AP9801234A0 (is)
AR (2)	AR011726A1 (is)
AU (1)	AU6932198A (is)
BG (1)	BG103852A (is)
BR (1)	BR9808720A (is)
CA (1)	CA2288759A1 (is)
DZ (1)	DZ2479A1 (is)
EA (1)	EA003696B1 (is)
GT (1)	GT199800063A (is)
HR (1)	HRP980244A2 (is)
HU (1)	HUP0001286A3 (is)
ID (1)	ID21311A (is)
IL (1)	IL132570A0 (is)
IS (1)	IS5220A (is)
MA (1)	MA26491A1 (is)
NO (1)	NO995389L (is)
NZ (1)	NZ500183A (is)
OA (1)	OA11213A (is)
PA (1)	PA8450601A1 (is)
PE (1)	PE72599A1 (is)
PL (1)	PL337003A1 (is)
SK (1)	SK148199A3 (is)
TN (1)	TNSN98059A1 (is)
TW (1)	TW590773B (is)
UY (1)	UY24989A1 (is)
WO (1)	WO1998050033A1 (is)
YU (1)	YU55899A (is)
ZA (1)	ZA983722B (is)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6245797B1 (en)	1997-10-22	2001-06-12	Merck & Co., Inc.	Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease
US6506785B2 (en)	1998-05-22	2003-01-14	Pfizer, Inc.	Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives
AU2003204888B2 (en) *	1998-05-22	2005-07-28	Pfizer Products Inc.	Treating or Preventing the Early Stages of Degeneration of Articular Cartilage or Subchondral Bone in Mammals Using Carprofen and Derivatives
EP1123091A1 (en) *	1998-10-23	2001-08-16	Merck Frosst Canada & Co.	Combination product comprising an e-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use
ATE306263T1 (de) *	1999-03-10	2005-10-15	Searle Llc	Zusammensetzungen zur verabreichung eines cyclooxygenase-2-hemmers an tiere
AU1592901A (en) *	1999-11-11	2001-06-06	Eli Lilly And Company	Oncolytic combinations for the treatment of cancer
WO2001087343A2 (en) *	2000-05-15	2001-11-22	Merck Frosst Canada & Co.	Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor
MXPA02012344A (es)	2000-06-13	2004-02-26	Wyeth Corp	Composiciones y anti-inflamatorias que contienen inhibidores cox-2.
DE10032132A1 (de) *	2000-07-01	2002-01-17	Lohmann Therapie Syst Lts	Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung
WO2002012445A1 (en)	2000-08-07	2002-02-14	Vanderbilt University	Detection of cox-2 activity and anandamide metabolites
AU2002354901A1 (en) *	2001-07-16	2003-03-03	Edward Hogestatt	Compounds with analgesic, antipyretic and/or anti-inflammatory activity
ES2275218T3 (es)	2003-05-07	2007-06-01	Osteologix A/S	Sales de estroncio hidrosolubles para el tratamiento de afecciones de cartilagos y/o huesos.
JP2007500691A (ja) *	2003-07-31	2007-01-18	ファルマシア・アンド・アップジョン・カンパニー・エルエルシー	抗炎症剤の分散性製剤
BRPI0610316A2 (pt) *	2005-05-20	2010-06-15	Pfizer Ltd	combinações sinergìsticas de medicamentos atiinflamatórios não estereoidais com alfa-delta-ligantes
ES2393814T3 (es)	2007-04-04	2012-12-28	Sigmoid Pharma Limited	Una composición farmacéutica oral
CA2685118C (en)	2007-04-26	2016-11-01	Sigmoid Pharma Limited	Manufacture of multiple minicapsules
ES2530049T3 (es)	2009-05-18	2015-02-26	Sigmoid Pharma Limited	Composición que comprende gotas de aceite
CN102573802A (zh)	2009-08-12	2012-07-11	希格默伊德药业有限公司	包含聚合物基质和油相的免疫调节组合物
GB201020032D0 (en)	2010-11-25	2011-01-12	Sigmoid Pharma Ltd	Composition
GB201212010D0 (en)	2012-07-05	2012-08-22	Sigmoid Pharma Ltd	Formulations
GB201319791D0 (en)	2013-11-08	2013-12-25	Sigmoid Pharma Ltd	Formulations
US12109218B2 (en)	2014-12-09	2024-10-08	Aratana Therapeutics, Inc.	Compositions of grapiprant and methods for using the same
PT3113774T (pt)	2014-03-06	2022-02-28	Elanco Animal Health Incorporated	Composições de grapiprant e métodos de utilização das mesmas
JP6716582B2 (ja)	2014-11-07	2020-07-01	サブリミティ・セラピューティクス・リミテッドＳｕｂｌｉｍｉｔｙＴｈｅｒａｐｅｕｔｉｃｓＬｉｍｉｔｅｄ	シクロスポリンを含む組成物
BR112017014750A2 (pt) *	2015-01-09	2018-06-19	Jaguar Animal Health	métodos para tratamento de diarreia em animais de estimação
CN115335046A (zh) *	2020-03-25	2022-11-11	思研（Sri）国际顾问与咨询公司	脂肪氧合酶抑制剂
US11116737B1 (en)	2020-04-10	2021-09-14	University Of Georgia Research Foundation, Inc.	Methods of using probenecid for treatment of coronavirus infections
KR102404883B1 (ko)	2020-11-30	2022-06-07	(주)이노보테라퓨틱스	벤즈브로마론을 포함하는 켈로이드 또는 비대흉터 예방 또는 치료용 약학 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3896145A (en) *	1972-07-24	1975-07-22	Hoffmann La Roche	Carbazoles
CA1319886C (en) *	1987-02-03	1993-07-06	Alberto Ferro	Mixed micelle solutions

1998
- 1998-03-02 DZ DZ980089A patent/DZ2479A1/xx active
- 1998-04-30 TW TW087106689A patent/TW590773B/zh not_active IP Right Cessation
- 1998-05-01 WO PCT/IB1998/000662 patent/WO1998050033A1/en not_active Ceased
- 1998-05-01 JP JP10547869A patent/JP2000513020A/ja active Pending
- 1998-05-01 SK SK1481-99A patent/SK148199A3/sk unknown
- 1998-05-01 HU HU0001286A patent/HUP0001286A3/hu unknown
- 1998-05-01 KR KR10-2003-7005258A patent/KR20040004406A/ko not_active Ceased
- 1998-05-01 AU AU69321/98A patent/AU6932198A/en not_active Abandoned
- 1998-05-01 BR BR9808720-7A patent/BR9808720A/pt not_active IP Right Cessation
- 1998-05-01 YU YU55899A patent/YU55899A/sh unknown
- 1998-05-01 CA CA002288759A patent/CA2288759A1/en not_active Abandoned
- 1998-05-01 EA EA199900895A patent/EA003696B1/ru not_active IP Right Cessation
- 1998-05-01 EP EP98915041A patent/EP0988034A1/en not_active Withdrawn
- 1998-05-01 CN CN98804845A patent/CN1255059A/zh active Pending
- 1998-05-01 NZ NZ500183A patent/NZ500183A/en unknown
- 1998-05-01 IL IL13257098A patent/IL132570A0/xx unknown
- 1998-05-01 ID IDP980651A patent/ID21311A/id unknown
- 1998-05-01 KR KR1019997010252A patent/KR20010012300A/ko not_active Ceased
- 1998-05-01 PL PL98337003A patent/PL337003A1/xx unknown
- 1998-05-04 PE PE1998000335A patent/PE72599A1/es not_active Application Discontinuation
- 1998-05-04 TN TNTNSN98059A patent/TNSN98059A1/fr unknown
- 1998-05-04 UY UY24989A patent/UY24989A1/es not_active Application Discontinuation
- 1998-05-04 ZA ZA9803722A patent/ZA983722B/xx unknown
- 1998-05-04 AP APAP/P/1998/001234A patent/AP9801234A0/en unknown
- 1998-05-04 MA MA25059A patent/MA26491A1/fr unknown
- 1998-05-04 GT GT199800063A patent/GT199800063A/es unknown
- 1998-05-05 HR HR60/045,635A patent/HRP980244A2/hr not_active Application Discontinuation
- 1998-05-05 PA PA19988450601A patent/PA8450601A1/es unknown
- 1998-05-05 AR ARP980102089A patent/AR011726A1/es unknown
1999
- 1999-10-19 IS IS5220A patent/IS5220A/is unknown
- 1999-11-02 OA OA9900242A patent/OA11213A/en unknown
- 1999-11-03 BG BG103852A patent/BG103852A/xx unknown
- 1999-11-04 NO NO995389A patent/NO995389L/no not_active Application Discontinuation
2003
- 2003-04-09 AR ARP030101251A patent/AR039628A2/es unknown

Also Published As

Publication number	Publication date
NO995389D0 (no)	1999-11-04
CA2288759A1 (en)	1998-11-12
PE72599A1 (es)	1999-08-12
EA199900895A1 (ru)	2000-06-26
CN1255059A (zh)	2000-05-31
PL337003A1 (en)	2000-07-31
KR20040004406A (ko)	2004-01-13
HUP0001286A2 (hu)	2000-11-28
NO995389L (no)	2000-01-04
AR011726A1 (es)	2000-08-30
ID21311A (id)	1999-05-20
JP2000513020A (ja)	2000-10-03
IL132570A0 (en)	2001-03-19
AP9801234A0 (en)	1999-11-04
HRP980244A2 (en)	1999-02-28
WO1998050033A1 (en)	1998-11-12
KR20010012300A (ko)	2001-02-15
OA11213A (en)	2003-07-14
PA8450601A1 (es)	2000-05-24
UY24989A1 (es)	2001-10-25
NZ500183A (en)	2002-04-26
BR9808720A (pt)	2000-07-11
EP0988034A1 (en)	2000-03-29
GT199800063A (es)	1999-10-26
BG103852A (en)	2000-06-30
HUP0001286A3 (en)	2000-12-28
TNSN98059A1 (fr)	2005-03-15
EA003696B1 (ru)	2003-08-28
ZA983722B (en)	1999-11-04
YU55899A (sh)	2003-08-29
TW590773B (en)	2004-06-11
AU6932198A (en)	1998-11-27
MA26491A1 (fr)	2004-12-20
AR039628A2 (es)	2005-03-02
DZ2479A1 (fr)	2003-02-01
SK148199A3 (en)	2001-09-11

Publication	Publication Date	Title
IS5220A (is)	1999-10-19	Sýkló-oxýgenasa-2 valvíst karprófen til meðhöndlunar á sársauka og bólgu hjá hundum
NO20005190L (no)	2000-11-30	Terapeutiske angiogene faktorer og fremgangsmåter til anvendelse derav
NO20014560D0 (no)	2001-09-19	Quinasoliner og terapautisk anvendelse derav
IS5405A (is)	2000-03-14	Prostaglandín gerandefni og notkun þeirra til að meðhöndla beintruflanir
DE69825447D1 (de)	2004-09-09	Gerät zur dermatologischen behandlung
IS2107B (is)	2006-05-15	Arýlsúlfónamíð og hliðstæður þeirra og notkun þeirra við meðhöndlun taugahrörnunarsjúkdóma
NO983576D0 (no)	1998-08-04	Brönnbehandlingsfluider og fremgangsmåter
NO20022656D0 (no)	2002-06-05	Caspaseinhibitorer og anvendelse derav
IS5921A (is)	2001-04-18	Staðgengnar Bensópýrahliðstæður til notkunar við meðhöndlun á bólgu
DE69911221D1 (de)	2003-10-16	Methode und gerät zur darreichung von therapeutischen mitteln in verbindung mit dem plazieren von radioaktiven körnern
IS5928A (is)	2001-04-27	Aðferðir og samsetningar til að hindra lyfjaþol
NO20004544D0 (no)	2000-09-12	Forbedret pumpeanordning og forbedrede fremgangsmÕter
IS5504A (is)	2000-05-19	Samsetning virk við meðhöndlun á getuleysi
ID18741A (id)	1998-05-07	Zat nikotinat dalam terapi
DE69701250D1 (de)	2000-03-09	Tierbehandlungsvorrichtung
IS4628A (is)	1997-12-04	Frumuröð sem myndar kvalastillandi efni til nota í meðferð gegn sársauka
PT932400E (pt)	2003-03-31	Derivados de anticonvulsionantes uteis no tratamento da dor neuropatica
NO20012738D0 (no)	2001-06-01	Terapeutiske produkter og anvendelse derav
IS5809A (is)	2001-01-12	Samtíma inngjöf ACAT og MMP tálma til meðhöndlunar á skemmdum vegna fituhrörnunar
ITMI20001555A0 (it)	2000-07-11	Procedimento e dispositivo di trattamento elettrochimico
DE69932577D1 (de)	2006-09-14	Stangenbehandlungsgerät und Stangenladegerät
DK0915655T3 (da)	2005-07-11	Fremgangsmåde og sammensætning til behandling mod parasitter i dyrs omgivelser
IS6428A (is)	2002-06-19	Aðferð og blanda til að meðhöndla sársauka
IS5324A (is)	1999-12-28	(S) 2-Metýlamínó-2-fenýl-n-bútýl 3,4,5-trímetoxý-bensóat, notkun þess til meðferðar á langvinnum sársauka
IS5857A (is)	2001-02-23	Aðferð til flökunar á fiski og flökunarvél til notkunar við flökunina